Summary
75 / 100 · Bulios Score
What speaks for it
- Revenue grew by 84% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Out of every 100 USD of revenue, only 5.6 USD is left as net profit.
- Earnings per share swing sharply from year to year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 1.7 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 84% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 52 USD
- Sales and administration 26 USD
- Taxes and other 16 USD
- Net profit 5.6 USD
Net profit, industry median (Financial - Capital Markets) 20 USD
Out of every 100 USD of revenue, 5.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 40.39%
- Paid out of profit
- 67%
You receive $0.75 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- New Issue and Advisory 82%
- Underwriting 16%
- Origination 1.0%
By region
- UNITED STATES 96%
- Non-US 3.6%
New Issue and Advisory brings in 82% of revenue.
Segments in detail